首页 | 本学科首页   官方微博 | 高级检索  
     

经皮氩氦靶向治疗肝癌的临床分析
引用本文:宋华志,易峰涛,刘英,李华章. 经皮氩氦靶向治疗肝癌的临床分析[J]. 中国肿瘤临床与康复, 2004, 11(2): 138-141
作者姓名:宋华志  易峰涛  刘英  李华章
作者单位:广州军区武汉总医院氩氦刀治疗中心,武汉,430070
摘    要:目的对184例原发性和转移性肝癌行氩氦靶向治疗,探讨其近期局部治疗效果、不良反应及并发症。方法局部麻醉,在B超或CT监视下,经皮穿刺靶向治疗。结果 184例中97例治疗时间在1年以上,1年生存率70.1%(68/97)。术后并发肝内出血4例(2.2%),肝区疼痛64例(34.8%),发热92例(50.0%)。结论 经皮氩氦靶向治疗肝癌是一种效果好、并发症少、安全可靠的局部治疗肝癌方法。

关 键 词:肝肿瘤  氩氦刀  靶向冷冻治疗
文章编号:1005-8664(2004)02-0138-04
修稿时间:2003-07-12

Clinical analysis of treatment of liver tumor with Ar-He target cryoablation
SONG Hua-zhi,YI Feng-tao,LIU Ying,et al. Clinical analysis of treatment of liver tumor with Ar-He target cryoablation[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2004, 11(2): 138-141
Authors:SONG Hua-zhi  YI Feng-tao  LIU Ying  et al
Abstract:Objective To investigate the local efficacy, adverse reaction and complication of 184 patients with hepatocellular carcinoma and metastasis treated with Ar-He target cryoablation. Method Using local anesthesia, under B-ultrasonography or computer tomography monitoring, 184 ptatients were treated with percutaneous Ar-He target cryoablation. Results Of the 184 patients,97 were followed up for longer than 12 months. The one-year survival rate was 70.1%(68 cases) . Complications were intrahepatic hemorrhage in 4 cases(2.2% ),liver pain in 64 cases(34.8%)and fever in 92 cases(50.0% ). Conclusion Percutaneous Ar-He target cryoablation was the effective, safe and reliable method for treatment of liver cancer.
Keywords:Liver neoplasm  Ar-He knife  Cryotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号